Effectiveness of Digital and Remote Health Interventions in Pediatric Populations From Underserved or Rural Areas: A

Víctor Beltrán1,2, Liliann Abarza1,2, Pablo Acuña-Mardones1,3

  • 1Clinical Investigation and Dental Innovation Center (CIDIC), Dental School and Center for Translational Medicine (CEMT-BIOREN), Universidad de La Frontera, Temuco, Chile, ufro.cl.

Insights

Digital health interventions like telehealth and mobile health (mHealth) show promise for improving pediatric care in underserved areas. These remote strategies are effective and feasible, enhancing health outcomes for children facing access barriers.

Area of Science:

  • Digital Health
  • Pediatric Health
  • Health Equity

Background:

  • Underserved and rural children face significant healthcare access barriers.
  • Geographic isolation, workforce shortages, and inequities limit pediatric care.
  • Digital and remote health interventions offer potential solutions.

Purpose of the Study:

  • To systematically review the evidence on digital and remote health interventions for children in underserved/rural settings.
  • To assess the effectiveness of telehealth, telemental health (TMH), and mobile health (mHealth).
  • To evaluate interventions against standard care using high-quality evidence.

Main Methods:

  • Systematic review following PRISMA 2020 guidelines and PROPS framework.
  • Searched five databases for randomized controlled trials (RCTs) up to May 2025.
  • Assessed risk of bias using Cochrane RoB 2.0 tool.

Main Results:

  • Eleven RCTs evaluated interventions for obesity, asthma, ADHD, diabetes, oral health, and neonatal care.
  • Telehealth improved behavioral and biometric outcomes; TMH effective for ADHD.
  • mHealth enhanced referral rates, service coverage, and caregiver engagement in LMICs.

Conclusions:

  • Digital health interventions are effective and feasible for pediatric outcomes in underserved settings.
  • Future research should focus on long-term impact, cost-effectiveness, and equity.
  • Sustainable and inclusive digital healthcare delivery requires addressing these factors.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Current Trends in Nursing II01:30

Current Trends in Nursing II

Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344